SureTrader SureTrader
Home > Boards > US Listed > Medical - Equipment > Navidea Biopharmaceuticals, Inc. (NAVB)

The old timers on IV sometimes have rose

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
sts66 Member Profile
 
Followed By 35
Posts 7,306
Boards Moderated 0
Alias Born 04/26/10
160x600 placeholder
Proxy Statement - Merger or Acquistion (preliminary) (prem14a) "Edgar (US Regulatory)" - 12/5/2016 4:46:46 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/30/2016 5:19:13 PM
Navidea Signs Asset Purchase Agreement with Cardinal Health "Business Wire" - 11/23/2016 3:13:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/9/2016 4:52:33 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/3/2016 8:02:02 AM
Navidea Reports 2016 Third Quarter Financial Results "Business Wire" - 11/3/2016 6:59:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/1/2016 10:29:58 AM
Navidea Biopharmaceuticals to Announce Third Quarter 2016 Financial Results on November 3, 2016 "Business Wire" - 10/27/2016 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/19/2016 11:49:31 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/18/2016 4:10:48 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/27/2016 6:02:26 AM
Navidea Appoints Michael M. Goldberg, M.D. President and Chief Executive Officer "Business Wire" - 9/26/2016 5:00:00 PM
Navidea Achieves $1 Million in Lymphoseek® Commercial Milestones "Business Wire" - 9/22/2016 6:59:00 AM
Navidea’s Lymphoseek® Receives Positive Opinion in Europe for a New Reduced Mass Vial "Business Wire" - 9/16/2016 8:15:00 AM
Navidea's Lymphoseek® Receives Positive Opinion in Europe for a New Reduced Mass Vial "PR Newswire (US)" - 9/16/2016 8:15:00 AM
Navidea to Present at Upcoming Investor Conferences "Business Wire" - 9/14/2016 7:00:00 AM
Navidea Biopharmaceuticals to Hold Investor Update Call "Business Wire" - 9/6/2016 3:21:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/6/2016 8:20:50 AM
Navidea Biopharmaceuticals Enters into Letter of Intent with Cardinal Health for the Sale of Lymphoseek® in North America "Business Wire" - 9/6/2016 6:59:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/31/2016 9:30:12 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/11/2016 5:16:58 PM
Navidea Biopharmaceuticals Announces 2016 Annual Meeting Results "Business Wire" - 8/11/2016 5:00:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/11/2016 4:04:57 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 8/10/2016 3:44:00 PM
Navidea Executes a Term Sheet with Cerveau Technologies to Sublicense NAV4694 "Business Wire" - 8/8/2016 5:00:00 PM
sts66   Wednesday, 04/24/13 08:06:49 PM
Re: hondadriver1973 post# 3569
Post # of 8951 
The old timers on IV sometimes have rose colored glasses on....they refuse to see manipulation.....being shorted by firms supposedly investing in NAVB....even the words "basher" or similar are not allowed by DDB....this just doesn't smell right to me.....and JPM apparently bought some for a 2nd unnamed investor again, same thing as last time....who are these mystery buyers and why are their names being kept a secret?

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist